{
    "clinical_study": {
        "@rank": "94239", 
        "arm_group": [
            {
                "arm_group_label": "Curodont Repair", 
                "arm_group_type": "Experimental", 
                "description": "Application on Day 0 and Day 360"
            }, 
            {
                "arm_group_label": "Fluoride", 
                "arm_group_type": "Active Comparator", 
                "description": "Application on Day 0, Day 180, Day 360, Day 540"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the therapeutic benefit of Curodont Repair for the\n      treatment of early approximal carious lesions compared to fluoride."
        }, 
        "brief_title": "Effect of Curodont\u2122 Repair in Patients With Early Approximal Carious Lesions", 
        "completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Dental Caries", 
        "condition_browse": {
            "mesh_term": "Dental Caries"
        }, 
        "detailed_description": {
            "textblock": "All study participants must have two early approximal carious lesions in need of a treatment\n      but not of an invasive treatment (split-mouth design). One lesion will be treated with\n      Curodont Repair and one with fluoride as control. Study duration is 24 months. For\n      assessment x-ray pictures, Diagnodent Pen and DiagnoCam is used."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Two approximal carious lesions on different teeth with at least one tooth in between\n\n          2. Both study lesions must not require an invasive treatment\n\n          3. Size and form of the lesions: the lesions must be fully visible and assessable on\n             radiographs\n\n          4. The two carious lesions must fall into classes:\n\n               -  D2 (inner half of enamel)\n\n               -  D3 (outer part of dentine) but only if very little dentine is involved\n                  (enamel-dentine junction)\n\n          5. Able and willing to observe good oral hygiene throughout the study\n\n          6. Age \u2265 18 years and \u2264 65 years\n\n          7. Willing and able to attend the on-study visits\n\n          8. Willing and able to understand all study-related procedures\n\n          9. Written informed consent before participation in the study\n\n        Exclusion Criteria:\n\n          1. The two study test lesions are located on adjacent teeth\n\n          2. Fluoride varnish application < 3 months prior to study treatment\n\n          3. Tooth with numerous carious lesions\n\n          4. Evidence of tooth erosion\n\n          5. History of head and neck illnesses (e.g. head/neck cancer)\n\n          6. Any pathology or concomitant medication affecting salivary flow or dry mouth\n\n          7. Any metabolic disorders affecting bone turnover\n\n          8. Patient suffers from diabetes\n\n          9. Concurrent participation in another clinical trial\n\n         10. Women who are breast-feeding, pregnant or who plan a pregnancy during the study\n\n         11. Women of childbearing potential who declare being unwilling or unable to practice\n             contraception such as hormonal contraceptives, sexual abstinence or intercourse with\n             a vasectomised partner"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 21, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02101255", 
            "org_study_id": "P11-4-RACL"
        }, 
        "intervention": [
            {
                "arm_group_label": "Curodont Repair", 
                "description": "Self-assembling peptide, biomimetic re-mineralisation\nApplication on Day 0 and Day 360", 
                "intervention_name": "Curodont Repair", 
                "intervention_type": "Device", 
                "other_name": "P11-4"
            }, 
            {
                "arm_group_label": "Fluoride", 
                "description": "Application on Day 0, Day 180, Day 360, Day 540", 
                "intervention_name": "Fluoride", 
                "intervention_type": "Device", 
                "other_name": "Duraphat"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Fluorides"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Dental caries", 
            "Curodont Repair", 
            "P11-4"
        ], 
        "lastchanged_date": "March 28, 2014", 
        "location": {
            "contact": {
                "email": "mathias.seifert@zahnarzt-sirnach.ch", 
                "last_name": "Mathias Seifert, Med. dent.", 
                "phone": "+41 71 966 55 44"
            }, 
            "facility": {
                "address": {
                    "city": "Sirnach", 
                    "country": "Switzerland", 
                    "state": "Thurgau", 
                    "zip": "8370"
                }, 
                "name": "Zahnheilkunde Seifert Gmbh"
            }, 
            "investigator": {
                "last_name": "Mathias Seifert, Med. dent.", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Curodont\u2122 Repair in Patients With Early Approximal Carious Lesions: A Mono-centre, Controlled, Single-blinded, Randomised, Split-mouth, Post-marketing Study", 
        "overall_contact": {
            "email": "mathias.seifert@zahnarzt-sirnach.ch", 
            "last_name": "Mathias Seifert, Med. dent.", 
            "phone": "+41 71 966 55 44"
        }, 
        "overall_official": {
            "affiliation": "Zahnheilkunde Seifert Gmbh", 
            "last_name": "Mathias Seifert, Med. dent.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Ethikkommission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary efficacy outcome is the difference of the change in the opaqueness of the carious lesion on the x-ray picture from Day 0 to Day 365 between test and control group.", 
            "measure": "Opaqueness on X-Ray", 
            "safety_issue": "No", 
            "time_frame": "Day 360"
        }, 
        "reference": {
            "PMID": "23969679", 
            "citation": "Brunton PA, Davies RP, Burke JL, Smith A, Aggeli A, Brookes SJ, Kirkham J. Treatment of early caries lesions using biomimetic self-assembling peptides--a clinical safety trial. Br Dent J. 2013 Aug;215(4):E6. doi: 10.1038/sj.bdj.2013.741."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02101255"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The secondary efficacy outcome is the difference of the change in the opaqueness of the carious lesion on the x-ray picture from Day 360 to Day 720 between test and control group.", 
            "measure": "Additional benefit of a second Curodont Repair application", 
            "safety_issue": "No", 
            "time_frame": "Day 720"
        }, 
        "source": "Credentis AG", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Credentis AG", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}